Transitional Care for Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias and Their Caregivers: a Cluster Randomized Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study is a parallel arm, cluster randomized trial (CRT) to test the efficacy of Connect-Home ADRD, a transitional care intervention focusing on Skilled Nursing Facility (SNF) patients with Alzheimer's disease and dementias and their caregivers during transitions from SNFs to home, assisted, living, and long-term care. The primary hypothesis is that the intervention will reduce caregiver strain (Aim 1) and patient neuropsychiatric symptoms (Aim 2).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:

⁃ Patients:

• Ability to speak English

• Goal of discharge to home, assisted living, or long-term care

• Diagnosis of dementia

• Having a caregiver willing to participate

⁃ Caregivers:

• Ability to speak English

• Legally authorized representative (LAR) who also provides support for the person with ADRD

• Location within 120 miles of UNC-Chapel Hill

• Admission of at least 75 SNF patients per year

Locations
United States
North Carolina
University of North Carolina at Chapel Hill
RECRUITING
Chapel Hill
Contact Information
Primary
Molly Lynch, MS
molly_lynch@unc.edu
9198438874
Backup
Kathryn Wessell, MPH
kwessell@email.unc.edu
919-966-2939
Time Frame
Start Date: 2025-04-04
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 360
Treatments
Experimental: Connect-Home ADRD Intervention
The Connect-Home ADRD Intervention will include:~1. Support for SNF staff delivery of transitional care processes including a ADRD transition plan and booklet, caregiver training and engagement, and handoff of care to community providers and Dementia Caregiving Specialist.~2. Support for patients and caregivers provided by the Dementia Caregiving Specialist in three follow-up supportive telephone calls within 30 days of SNF discharge.
No_intervention: Standard Care - Control Group
Patient and caregiver dyad randomized to the control arm will receive usual SNF and post-discharge care.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Nursing Research (NINR)
Leads: University of North Carolina, Chapel Hill

This content was sourced from clinicaltrials.gov